Literature DB >> 17063995

Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation.

C Mathieu1, M Jafari.   

Abstract

The active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3, is a secosteroid hormone that regulates calcium and bone metabolism, controls cell proliferation and differentiation, and plays an important role as an immunomodulator. Recent advances in understanding the mechanisms underlying 1,25(OH)2D3 immune actions expand the range of the therapeutic implications of 1,25(OH)2D3 and its analogs. This review will cover the current knowledge on vitamin D-mediated immunotolerance and recent advances in vitamin D-based therapies for the treatment of autoimmune disease and the prevention of graft rejection in renal transplantation. Initiation of vitamin D-based therapies at earlier stages of chronic kidney disease may impact the immune status of patients who progress to require dialysis or transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17063995     DOI: 10.5414/cnp66275

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  13 in total

Review 1.  Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Authors:  Wacharee Seeherunvong; Myles Wolf
Journal:  Pediatr Transplant       Date:  2010-10-08

Review 2.  The immunoregulatory function of vitamin D: implications in chronic kidney disease.

Authors:  Kevin A Sterling; Parham Eftekhari; Matthias Girndt; Paul L Kimmel; Dominic S Raj
Journal:  Nat Rev Nephrol       Date:  2012-05-22       Impact factor: 28.314

3.  Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

Authors:  Patrícia João Matias; Cristina Jorge; Carina Ferreira; Marília Borges; Inês Aires; Tiago Amaral; Célia Gil; José Cortez; Aníbal Ferreira
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

4.  Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Authors:  Myles Wolf; Miklos Z Molnar; Ansel P Amaral; Maria E Czira; Anna Rudas; Akos Ujszaszi; Istvan Kiss; Laszlo Rosivall; Janos Kosa; Peter Lakatos; Csaba P Kovesdy; Istvan Mucsi
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

5.  Serum phosphate levels and risk of infection in incident dialysis patients.

Authors:  Laura C Plantinga; Nancy E Fink; Michal L Melamed; William A Briggs; Neil R Powe; Bernard G Jaar
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 8.237

6.  Gene expression profiles identify inflammatory signatures in dendritic cells.

Authors:  Anna Torri; Ottavio Beretta; Anna Ranghetti; Francesca Granucci; Paola Ricciardi-Castagnoli; Maria Foti
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

7.  Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients.

Authors:  Don Vu; Prashant Sakharkar; Eglis Tellez-Corrales; Tariq Shah; Ian Hutchinson; David I Min
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

8.  Characterization of acute renal allograft rejection by human serum proteomic analysis.

Authors:  Ying Gao; Ke Wu; Yi Xu; Hongmin Zhou; Wentao He; Weina Zhang; Lanjun Cai; Xingguang Lin; Zemin Fang; Zhenlong Luo; Hui Guo; Zhonghua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

9.  Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response.

Authors:  Jun Tang; Ru Zhou; Dror Luger; Wei Zhu; Phyllis B Silver; Rafael S Grajewski; Shao-Bo Su; Chi-Chao Chan; Luciano Adorini; Rachel R Caspi
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.

Authors:  Ursula Thiem; Georg Heinze; Rudolf Segel; Thomas Perkmann; Franz Kainberger; Ferdinand Mühlbacher; Walter Hörl; Kyra Borchhardt
Journal:  Trials       Date:  2009-05-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.